Cognitive behavioural therapy for chronic fatigue and chronic fatigue syndrome: outcomes from a specialist clinic in the UK.


Journal

Journal of the Royal Society of Medicine
ISSN: 1758-1095
Titre abrégé: J R Soc Med
Pays: England
ID NLM: 7802879

Informations de publication

Date de publication:
10 2020
Historique:
pubmed: 16 9 2020
medline: 23 12 2020
entrez: 15 9 2020
Statut: ppublish

Résumé

Cognitive behavioural therapy is commonly used to treat chronic fatigue syndrome and has been shown to be effective for reducing fatigue and improving physical functioning. Most of the evidence on the effectiveness of cognitive behavioural therapy for chronic fatigue syndrome is from randomised control trials, but there are only a few studies in naturalistic treatment settings. Our aim was to examine the effectiveness of cognitive behavioural therapy for chronic fatigue syndrome in a naturalistic setting and examine what factors, if any, predicted outcome. Using linear mixed effects analysis, we analysed patients' self-reported symptomology over the course of treatment and at three-month follow-up. Furthermore, we explored what baseline factors were associated with improvement at follow-up. Data were available for 995 patients receiving cognitive behavioural therapy for chronic fatigue syndrome at an outpatient clinic in the UK. Participants were referred consecutively to a specialist unit for chronic fatigue or chronic fatigue syndrome. Patients were assessed throughout their treatment using self-report measures including the Chalder Fatigue Scale, 36-item Short Form Health Survey, Hospital Anxiety and Depression Scale and Global Improvement and Satisfaction. Patients' fatigue, physical functioning and social adjustment scores significantly improved over the duration of treatment with medium to large effect sizes (|d| = 0.45-0.91). Furthermore, 85% of patients self-reported that they felt an improvement in their fatigue at follow-up and 90% were satisfied with their treatment. None of the regression models convincingly predicted improvement in outcomes with the best model being (R Patients' fatigue, physical functioning and social adjustment all significantly improved following cognitive behavioural therapy for chronic fatigue syndrome in a naturalistic outpatient setting. These findings support the growing evidence from previous randomised control trials and suggest that cognitive behavioural therapy could be an effective treatment in routine treatment settings.

Identifiants

pubmed: 32930040
doi: 10.1177/0141076820951545
pmc: PMC7583448
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

394-402

Commentaires et corrections

Type : CommentIn
Type : CommentIn
Type : CommentIn
Type : CommentIn

Références

Behav Res Ther. 2014 Dec;63:1-8
pubmed: 25222752
Psychol Med. 2013 Feb;43(2):375-80
pubmed: 22571806
Am J Psychiatry. 1997 Mar;154(3):408-14
pubmed: 9054791
Br J Psychiatry. 2011 Nov;199(5):430-1
pubmed: 21903665
Lancet. 2011 Mar 5;377(9768):823-36
pubmed: 21334061
J Psychosom Res. 2011 Sep;71(3):124-8
pubmed: 21843745
Acta Psychiatr Scand. 1983 Jun;67(6):361-70
pubmed: 6880820
Psychother Psychosom. 2007;76(3):171-6
pubmed: 17426416
Br J Psychiatry. 2002 Sep;181:248-52
pubmed: 12204931
Psychol Med. 2014 Apr;44(6):1331-44
pubmed: 23931831
J Clin Epidemiol. 1998 Nov;51(11):1105-13
pubmed: 9817128
BMJ Open. 2014 Feb 07;4(2):e003973
pubmed: 24508851
QJM. 2013 Jun;106(6):555-65
pubmed: 23538643
Br J Psychiatry. 2005 Apr;186:350-1
pubmed: 15802694
Clin Psychol Rev. 2008 Jun;28(5):736-45
pubmed: 18060672
BMJ. 1994 Mar 19;308(6931):763-6
pubmed: 7908238
J Psychosom Res. 2017 Jun;97:45-51
pubmed: 28606498
Behav Res Ther. 2007 Jun;45(6):1085-94
pubmed: 17074300
Psychother Res. 2011 Mar;21(2):168-78
pubmed: 21271461
Cochrane Database Syst Rev. 2008 Jul 16;(3):CD001027
pubmed: 18646067
J Psychosom Res. 2002 Feb;52(2):69-77
pubmed: 11832252
Ann Intern Med. 1994 Dec 15;121(12):953-9
pubmed: 7978722
J Affect Disord. 2010 Oct;126(1-2):174-9
pubmed: 20167377
J Psychosom Res. 2010 Jul;69(1):17-22
pubmed: 20630259
J R Soc Med. 1991 Feb;84(2):118-21
pubmed: 1999813
J Psychosom Res. 1993;37(2):147-53
pubmed: 8463991

Auteurs

James Adamson (J)

Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, Kings College London, London SE5 8AF, UK.

Sheila Ali (S)

Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, Kings College London, London SE5 8AF, UK.

Alastair Santhouse (A)

Persistent Physical symptoms Research and Treatment Unit, South London and Maudsley NHS Foundation Trust, London, SE5 8AZ, UK.

Simon Wessely (S)

Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, Kings College London, London SE5 8AF, UK.
Persistent Physical symptoms Research and Treatment Unit, South London and Maudsley NHS Foundation Trust, London, SE5 8AZ, UK.

Trudie Chalder (T)

Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, Kings College London, London SE5 8AF, UK.
Persistent Physical symptoms Research and Treatment Unit, South London and Maudsley NHS Foundation Trust, London, SE5 8AZ, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH